Balyasny Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.05M Sell
11,500
-57,800
-83% -$20.6M 0.01% 1456
2025
Q4
$22.7M Buy
69,300
+27,100
+64% +$8.6M 0.03% 649
2025
Q3
$11.9M Buy
42,200
+20,600
+95% +$5.97M 0.02% 965
2025
Q2
$6.03M Sell
21,600
-15,000
-41% -$4.25M 0.01% 1196
2025
Q1
$11.4M Buy
36,600
+21,700
+146% +$6.41M 0.02% 845
2024
Q4
$3.88M Sell
14,900
-8,200
-35% -$2.43M 0.01% 1395
2024
Q3
$7.44M Buy
23,100
+7,300
+46% +$2.39M 0.01% 1084
2024
Q2
$4.94M Buy
15,800
+14,400
+1,029% +$4.23M 0.01% 1176
2024
Q1
$398K Sell
1,400
-4,700
-77% -$1.38M ﹤0.01% 2145
2023
Q4
$1.76M Buy
6,100
+5,000
+455% +$1.36M ﹤0.01% 1494
2023
Q3
$296K Buy
+1,100
New +$275K ﹤0.01% 1916
2021
Q3
Sell
-5,700
Closed -$1.39M 1904
2021
Q2
$1.39M Buy
+5,700
New +$1.4M 0.01% 1161
2016
Q3
Sell
-75,000
Closed -$11.4M 990
2016
Q2
$11.4M Buy
+75,000
New +$11.7M 0.07% 321
2015
Q3
Sell
-100,000
Closed -$15.4M 1135
2015
Q2
$15.4M Buy
+100,000
New +$16M 0.09% 276

Other funds holding AMGN

Balyasny Asset Management's AMGN Position: Q1 2026 in Review

Balyasny Asset Management reduced its Amgen (AMGN) stake by 42% in Q1 2026, selling an estimated $2.03M and leaving 7,980 shares worth $2.81M. The position accounts for ﹤0.01% of the portfolio, ranked #1628.

Balyasny Asset Management first reported a position in AMGN in Q3 2014 and has held it in 35 quarters since. The position peaked at $96.1M in Q3 2024. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Balyasny Asset Management held 7,980 shares of Amgen worth $2.81M as of Q1 2026.
  • Balyasny Asset Management sold 5,688 Amgen shares in Q1 2026, an estimated $2.03M.
  • Amgen made up ﹤0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #1628 holding.
  • Balyasny Asset Management first reported a position in Amgen in Q3 2014 and has held it in 35 quarters since.
  • Balyasny Asset Management's Amgen position peaked at $96.1M in Q3 2024.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.